HIV/AIDS Treatment and Prevention

NEW DELHI, August 13, 2004—As the Government of India takes stock of its first four months of distributing free antiretroviral medications for HIV/AIDS, the World Bank has released a study of various public funding options for the months and years ahead, designed to help the government maximize the positive impact of the drugs on the growing epidemic.

The study, HIV/AIDS Treatment and Prevention in India:  Costs and Consequences of Policy Options, focuses on ways the government can provide sustainable antiretroviral therapy (ART) to the greatest number of people while avoiding dangerous pitfalls such as the development of drug-resistant strains of HIV and a surge in risky behavior by people who mistakenly assume the drugs are a cure for HIV/AIDS.

Purchase a printed copy

Read the full report. [156 pages, 470 kb adobe pdf]

Presentation by researchers [759kb MS PowerPoint]